pulmonary 

16514
单词释义
adj.肺的,肺部的,与肺有关的
词根词缀记忆/谐音联想记忆 补充/纠错
词组和短语补充/纠错
chronic obstructive pulmonary disease 慢性阻塞性肺病
pulmonary tuberculosis 肺结核
pulmonary resuscitation 肺复苏术
单词例句
The patient's pulmonary function test showed a significant decline.
这位病人的肺功能测试显示出显著下降。
Smoking is a major risk factor for developing pulmonary diseases.
吸烟是引发肺部疾病的主要风险因素。
She underwent a bronchoscopy to diagnose her persistent pulmonary infection.
她接受了支气管镜检查以诊断她的持续性肺部感染。
Pulmonary edema occurs when fluid accumulates in the lungs, making breathing difficult.
肺水肿是指肺部积液,导致呼吸困难。
The doctor prescribed bronchodilators to treat his patient's obstructive pulmonary disease.
医生给患者的阻塞性肺病开了扩张气道药物。
Pulmonary rehabilitation helps patients recover from lung injuries or surgeries.
肺功能康复帮助患者从肺部损伤或手术中恢复。
The patient was discharged from the hospital after completing pulmonary rehabilitation.
患者在完成肺功能康复后出院。
Smoking cessation can improve a person's overall pulmonary health.
戒烟可以提高一个人的整体肺部健康状况。
Pulmonary embolism is a serious condition caused by blood clots traveling to the lungs.
肺栓塞是由血栓进入肺部引起的一种严重状况。
Regular exercise can strengthen the respiratory muscles and enhance pulmonary efficiency.
定期锻炼能增强呼吸肌力,提高肺部功能效率。
The investment was announced at an industry conference about the comprehensive prevention and control of hypertension, hyperlipidemia and hyperglycemia as well as three major chronic diseases: chronic heart failure, chronic kidney disease, and chronic obstructive pulmonary disease.
这项投资是在一次关于高血压、高脂血症和高血糖以及三大慢性病(慢性心力衰竭、慢性肾脏病和慢性阻塞性肺病)综合防治的行业会议上宣布的。
During the CIIE, Boehringer Ingelheim also exhibited a new drug candidate at the Phase-3 clinical trial for treating idiopathic pulmonary fibrosis, a rare and chronic lung disease.
在CIIE期间,勃林格殷格翰还在治疗特发性肺纤维化(一种罕见的慢性肺病)的3期临床试验中展示了一种新的候选药物。
Since 2019, the Japanese company has launched MMC, or metabolic management centers, a kind of health convenience store that mainly help patients with daily chronic disease screening services, such as high blood pressure, arteriosclerosis and pulmonary ailments.
自2019年以来,这家日本公司推出了MMC或代谢管理中心,这是一种健康便利店,主要帮助患者提供日常慢性病筛查服务,如高血压、动脉硬化和肺部疾病。
"In the field of human pharma, the company will present innovative products for rare skin diseases, obesity, pulmonary fibrosis, mental health, and cancer at the CIIE.
“在人类制药领域,该公司将在进博会上展示针对罕见皮肤病、肥胖、肺纤维化、精神健康和癌症的创新产品。
Regarding this year's public welfare program, He Xuzheng, vice-president of Janssen China's Immunology and Pulmonary Hypertension Department, said: "As an innovative pharmaceutical company which entered the Chinese market 38 years ago, Janssen has been always committed to providing Chinese patients with high-quality, innovative products.
关于今年的公益计划,杨森中国免疫与肺动脉高压部副总裁何旭正表示:“作为一家38年前进入中国市场的创新制药公司,杨森一直致力于为中国患者提供高质量、创新的产品。
For example, in a clinical study regarding the first inhalation therapy that only needs to be taken once daily to treat chronic obstructive pulmonary disease (COPD), which was marketed in China in 2019, Chinese patients were recruited at the same time research kicked off globally.
例如,在2019年在中国上市的第一种治疗慢性阻塞性肺病(COPD)的吸入疗法的临床研究中,在全球研究启动的同时,招募了中国患者。
Global pharmaceutical company AstraZeneca will introduce a batch of innovative drugs into China by 2025 for the treatment of respiratory diseases, such as severe asthma, chronic cough and chronic obstructive pulmonary disease, according to Lin Xiao, vice-president of the company's China branch.
全球制药公司阿斯利康中国分公司副总裁林晓表示,到2025年,该公司将向中国引进一批创新药物,用于治疗严重哮喘、慢性咳嗽和慢性阻塞性肺病等呼吸道疾病。
In recent years, Chiesi's portfolio of products has expanded from mainly neonatology to include respiratory solutions for all age groups, especially those who have respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease.
近年来,Chiesi的产品组合已从主要的新生儿科扩展到包括适用于所有年龄组的呼吸系统解决方案,尤其是那些患有哮喘和慢性阻塞性肺病等呼吸系统疾病的人。
According to recent pulmonary health studies among the Chinese population, 4.2 percent of adults aged above 20 in the country suffer from asthma.
根据最近在中国人群中进行的肺部健康研究,中国20岁以上的成年人中有4.2%患有哮喘。
COPD, an inflammatory lung disease that causes obstructed airflow in the lungs, is even more widespread-close to 100 million of the country's adult population suffer from this chronic pulmonary disease, which has become the third leading cause of death in China.
慢性阻塞性肺病是一种导致肺部气流受阻的炎症性肺病,其传播范围更广——中国近1亿成年人口患有这种慢性肺病,已成为中国第三大死亡原因。
During this year's CIIE, Omron Healthcare also signed strategic cooperation agreements with Jiangsu Dazhong Pharmaceuticals Group for its MMC, or metabolic management centers, health convenience stores that mainly help patients with daily chronic disease screening services, such as high blood pressure, arteriosclerosis and pulmonary ailments.
在今年的CIIE期间,奥姆龙医疗还与江苏大中制药集团签署了战略合作协议,建立MMC或代谢管理中心、健康便利店,主要帮助患者提供日常慢性病筛查服务,如高血压、动脉硬化和肺病。
British pharmaceutical company GlaxoSmithKline said that an innovative therapy to treat chronic obstructive pulmonary disease, which only needs to be taken once daily, attracted attention from medical circles and visitors during the 2019 CIIE, and was listed on the NRDL the following year.
英国制药公司葛兰素史克表示,在2019年中国国际进口博览会上,一种创新的慢性阻塞性肺疾病治疗方法吸引了医学界和参观者的关注,该疗法只需每日服用一次。次年,这一疗法被列入国家医保目录(NRDL)。这里的NRDL指的是国家基本医疗保险、工伤保险和生育保险药品目录,也就是我们通常说的“国家医保目录”。被列入这个目录意味着药品的价格会得到政府的支持,患者可以享受到医保报销,从而减轻经济负担。这表明葛兰素史克的创新疗法不仅在国际舞台上受到认可,也得到了中国政府的支持,将为更多的中国患者提供治疗选择。
Insilico Medicine demonstrated the first case of AI identifying a novel target for a major pulmonary disease, generating novel molecules for that novel target, and completing the preclinical experiments required to nominate a preclinical candidate in under 18 months.
Insilico Medicine 展示了首例人工智能识别出针对一种主要肺部疾病的新靶点,为该新靶点生成新分子,并在不到18个月的时间内完成提名临床前候选药物所需的所有临床前实验。
Omron Healthcare also signed agreements with seven chain pharmacies, including JD Health, to launch MMC, or metabolic management centers, and health convenience stores, which mainly help patients with daily chronic disease screening services, such as high blood pressure, arteriosclerosis and pulmonary ailments.
此外,欧姆龙还与包括京东健康在内的七家连锁药店签署了协议,开设MMC(代谢管理中心)和健康便利商店。这些中心和商店主要帮助患者进行日常慢性疾病筛查服务,例如高血压、动脉硬化和肺部疾病。
The company and the hospital will explore e-hospital-based approaches to improve patient treatment compliance and treatment maintenance for different diseases, starting with hematology, solid tumors, immunology and pulmonary arterial hypertension, to achieve better treatment outcomes.
该公司和医院将探讨以电子化医院为基础的方法,以提升患者对不同疾病(如血液病、实体瘤、免疫学疾病和肺动脉高压)的治疗遵从性和治疗维持,旨在实现更好的治疗效果。
In terms of pharmaceuticals, the company has started a trial in Yinchuan, the capital city of Ningxia Hui autonomous region, leveraging big data to manage and monitor in real-time the whereabouts of patients with chronic obstructive pulmonary disease.
在医药领域,该公司已在宁夏回族自治区首府银川启动了一项试验,利用大数据实时管理并追踪慢性阻塞性肺病患者的情况。
Moreover, the disease may lead to complications, including asthma and chronic obstructive pulmonary disease.
此外,这种疾病可能导致并发症,包括哮喘和慢性阻塞性肺病。
The services will first start with patients suffering from blood cancers, solid cancers, immunology, and pulmonary arterial hypertension.
The Chinese doctors who specialize in such areas as infectious disease prevention, pulmonary and critical care medicine, will also share their practical medical experiences with others in Nigeria.
The Chinese doctors, who specialize in such areas as infectious disease prevention, pulmonary and critical care medicine, also will share their practical medical experiences in Nigeria, which demanded its citizens remain indoors in Lagos, Abuja and Ogun state for 14 days, starting from last Monday.
The current oxygen demand at Wuhan's hospitals exceed 10 times the previous daily peak volume, Peng Peng, head of Wuhan Pulmonary Hospital, said during a news conference on Feb 7.
There were about 290 million patients with cardiovascular diseases in China, including 13 million with stroke, 11 million with coronary heart disease, 5 million with pulmonary heart disease, 4.5 million with heart failure, 2 million with rheumatic heart disease, and 245 million with hypertension, according to the report.
China's medical AI has developed rapidly over a short period of time, but many can only detect pulmonary nodules — small rounds or growths in lung, according to Jin Zhengyu, chairman of Chinese Society of Radiology.
That provides little assistance to radiologists in clinical practice, because pulmonary nodules only account for about 50 percent of lung lesions in a chest CT, Jin said.
Besides, the company's first AI-discovered drug candidate, for the treatment of a rare and chronic lung disease called idiopathic pulmonary fibrosis, has finished dosing subjects for a phase-1 clinical study in China.
At the booth of Sanofi, innovative biological agent Dupixent made its global debut for the indication of chronic obstructive pulmonary diseases.
At the booth of Sanofi, the indication of Dupixent for chronic obstructive pulmonary disease (COPD) will be given its world debut.
For human pharmaceuticals, the company will present innovative products for rare skin diseases, obesity, pulmonary fibrosis, mental health and cancer.
Insilico Medicine, an end-to-end AI-driven drug discovery company with a key research and development team based in Shanghai, announced on Feb 24 it had dosed multiple healthy volunteers in the phase-1 clinical trial to evaluate the safety of ISM001-055, the first anti-fibrotic small molecule inhibitor generated by its AI-powered drug discovery platform for idiopathic pulmonary fibrosis.
GlaxoSmithKline announced it would promote a "happy breathing" initiative, which it had begun with the China Association of Health Promotion and Education in 2017 to standardize diagnosis and treatment of chronic obstructive pulmonary disease, or COPD.
Wu's father suffers from chronic obstructive pulmonary disease, and inhalers have been in short supply.
The company announced recently that it has found a new therapeutic target and potential therapy candidate for idiopathic pulmonary fibrosis, or IPF, through AI technologies.
According to the World Health Organization, exposure to PM2.5 can cause cardiovascular and respiratory diseases such as stroke, lung cancer and chronic obstructive pulmonary disease.
未经许可,严禁转发。QQ交流群:688169419
0
0